Later, in the study by Rzhevskiy et al. [117], the same anti-GPC-1 antibody MIL-38 was applied for detecting PCa tumor cells isolated from large volumes (30–100 mL) of urine with a microfluidic chip. The gene discussed is GPC1; the disease is posterior cortical atrophy.